Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist.
about
Ketamine controls prolonged status epilepticusA comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients.Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain.The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activationSprouty2 and -4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damageStatus epilepticus: the past and the future.A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.An Immunological Approach to Increase the Brain's Resilience to Insults.Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia.Excitotoxicity and selective neuronal loss in epilepsy.Pathophysiological mechanisms of brain damage from status epilepticus.Epilepsy in the developing brain: lessons from the laboratory and clinic.Reversible magnetic resonance imaging abnormalities in dogs following seizures.Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administrationRole of kynurenines in the neurotoxic actions of kainic acid.Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms.Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection.Caspase-3 is not activated in seizure-induced neuronal necrosis with internucleosomal DNA cleavage.Selective excitotoxic pathology in the rat hippocampus.Synergism between topiramate and budipine in refractory status epilepticus in the rat.Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy.Tetrodotoxin prevents posttraumatic epileptogenesis in rats.Differential subcellular redistribution of protein kinase C isozymes in the rat hippocampus induced by kainic acid.A low dose of streptozotocin prevents kainic acid-induced seizures and lethal effects in the rat.Relationship between GAP-43 expression in the dentate gyrus and synaptic reorganization of hippocampal mossy fibres in rats treated with kainic acid.Isoflurane for 7 days in refractory status epilepticus.Neuroprotective effect of ketamine administered after status epilepticus onset.
P2860
Q30306363-EE00CAFB-C12B-4BC4-9719-C23DC2F9C7C8Q30433508-BD77A5F9-A25D-46D4-A307-214C3EDF03E1Q30495774-305992F2-95F0-4F88-B588-E8D7CA979D0CQ33912386-C243C32C-915F-432E-B6B2-9C08EA8E56FFQ35086841-0DE15414-F6E4-459A-8B12-ECFC3A665A42Q37105229-1AC20525-ECBE-4306-9096-998BAA962549Q37105984-C3ADD79D-0F2A-4867-8716-1F34E4C04D3AQ37300227-E24DAA69-1937-47CF-9A57-A5CE5A7E0A86Q39266351-7DC2210D-8C47-45AC-941E-3D06D903B45BQ40444545-24CBE0F9-CA96-4973-B4E4-4DF5010B4B64Q40807326-B87B42CD-2849-49C2-BE2B-89DA7B70C428Q40852693-E2DC5BEE-6575-4469-9541-D4CE93CC6093Q41344970-32BE3A12-4AA4-475A-8606-63AF19291C9BQ41710367-D2E2D091-7878-40E6-9C77-7EEE9C57D53FQ41857010-9E3FB2ED-3DD7-43D9-AFCE-244CD4F77069Q42737220-42A12951-4336-47B0-B8BF-EC7ACC5C2FF1Q43263753-FBAF3A77-96BD-49C3-B5ED-0FC42B04CDB8Q43507386-C569DFC1-076C-4B69-9EF9-9B0DBD83FA84Q44066396-34046E45-D9AB-4773-BD6C-B0EBB8FE6454Q44088641-89B971E2-C234-4AED-837C-F8B28C6B9725Q44163182-0AC02E44-A7C9-47E7-91F3-FAC5021C9BD9Q45091199-289F57D4-F4FD-45D6-B5E9-FEB5568DE580Q45127636-64793146-925A-46D1-9BB2-EB87C9F23E40Q45243586-0917EA16-F4E8-48C4-9D55-B4EF3DB45920Q48138876-CA067984-37D1-49DC-9C96-3C2824DF5074Q48251030-C8DA746B-B6BA-4E4B-A741-AED68767FE59Q48667435-B22E4D5C-5098-4538-8C4B-C64B8B08D26FQ48807009-7AC892CE-0CC1-4C84-9CC9-99D449C632E8Q51606039-263B729A-82C3-4055-8528-2D1F95B3648DQ51611181-9D92E53E-97A0-4EFB-BE0C-94E6B29A92F3
P2860
Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@en
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@nl
type
label
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@en
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@nl
prefLabel
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@en
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@nl
P2093
P1433
P1476
Potentiation of kainic acid ep ...... y an NMDA receptor antagonist.
@en
P2093
P304
P356
10.1016/0920-1211(89)90025-9
P577
1989-05-01T00:00:00Z